HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new combo targets Hard-to-Treat biliary cancer
Disease control OngoingThis study tests a three-drug combination (chemotherapy plus two targeted therapies) as a first treatment for people with a specific type of bile duct or gallbladder cancer that cannot be removed by surgery. The goal is to see if the combination shrinks tumors and improves surviv…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
AI could replace biopsies for bladder cancer testing
Diagnosis ENROLLING_BY_INVITATIONThis study enrolls 4,000 people with bladder cancer to see if artificial intelligence can predict HER2 protein levels from MRI scans and tissue samples. If successful, patients may avoid invasive biopsies to determine if they are candidates for targeted therapy. The goal is faste…
Matched conditions: HER2
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Diagnosis
Last updated Jun 17, 2026 04:09 UTC